M. Trigo-Rodríguez

Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection

A. Aller, J. Rodríguez, E. Merino, 2022, Anaerobe.

Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection

A. Aller, J. Rodríguez, E. Merino, 2022, Anaerobe.

Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention.

L. Real, J. Macías, J. Pineda, 2022, Enfermedades infecciosas y microbiologia clinica.

Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial

R. León-López, J. Torre-Cisneros, D. V. García, 2021, Antimicrobial agents and chemotherapy.

High incidence of asymptomatic phase I IgG seroconversion after acute Q fever episode: implications for chronic Q fever diagnosis.

C.F.B. Castro, S. Bernal, J. Corzo, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

A. Aller, M. García-López, E. Merino, 2023, JAC-antimicrobial resistance.

Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

A. Aller, M. García-López, E. Merino, 2023, JAC-antimicrobial resistance.